We compared the effectiveness of several recombinant
influenza and vaccinia viruses to induce a
malaria-specific immune response. The CD8+
T cell epitope of the circumsporozoite (CS)
protein of Plasmodium yoelii, a rodent
malaria parasite, was expressed in two distinct influenza virus
proteins, the
hemagglutinin and the
neuraminidase. These recombinant viruses were found to be equally efficient at inducing CS-specific CD8+ T cells in mice. A third recombinant virus, which expresses a
B cell epitope of the CS
protein, induced neutralizing anti-sporozoite Abs. Expression in the same recombinant virus of the CD8+
T cell epitope and of the
B cell epitope did not impair the capacity of this recombinant virus to induce
malaria-specific CD8+ T cells and neutralizing Abs. The immunogenicity of a vaccinia virus, expressing the entire CS
protein, was compared with that of a highly attenuated
vaccinia strain expressing the same
protein and with that of another vaccinia virus expressing only the CD8+
T cell epitope. All three vaccinia virus recombinants elicited CS-specific CD8+ cells and a potent inhibitory response against pre-erythrocytic stages of
malaria parasites. Optimal levels of anti-sporozoite Abs, inhibition of liver stage development, and protection against
malaria infection resulted from repeatedly immunizing the animals with recombinant influenza viruses followed by boosters with a recombinant vaccinia virus. These findings support the concept that live viral vectors expressing the appropriate
proteins and/or
epitopes can be used as promising
vaccine candidates.